Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Neuropharmacology. 2023 Jun 5;237:109601. doi: 10.1016/j.neuropharm.2023.109601

Fig. 4.

Fig. 4.

LY2828360 (10 mg/kg i.p.) increased mechanical paw withdrawal thresholds in paw ipsilateral but not contralateral to carrageenan injection in female CB2f/f and CX3CR1CRE/+; CB2f/f mice (n = 4–10 per group). LY2828360 (10 mg/kg i.p.) did not alter paw withdrawal thresholds in paw ipsilateral or contralateral to carrageenan injection in female AdvillinCRE/+; CB2f/f mice (n = 7 per group). Mean (± SEM) threshold for the ipsilateral and contralateral paw in Experiment 5, 6, 7 and 9. **p < 0.01 vs. VEH.